Matches in Nanopublications for { ?s ?p "[Primary hyperoxaluria type II (PH2) is a rare monogenic disorder that is characterized by a lack of the enzyme that catalyzes the reduction of hydroxypyruvate to D-glycerate, the reduction of glyoxylate to glycolate and the oxidation of D-glycerate to hydroxypyruvate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- assertion description "[Primary hyperoxaluria type II (PH2) is a rare monogenic disorder that is characterized by a lack of the enzyme that catalyzes the reduction of hydroxypyruvate to D-glycerate, the reduction of glyoxylate to glycolate and the oxidation of D-glycerate to hydroxypyruvate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_assertion description "[Primary hyperoxaluria type II (PH2) is a rare monogenic disorder that is characterized by a lack of the enzyme that catalyzes the reduction of hydroxypyruvate to D-glycerate, the reduction of glyoxylate to glycolate and the oxidation of D-glycerate to hydroxypyruvate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP262853.RAQxlP_t4Oa1t3QqiiLv6SIQfkpXXJwLV4O59gx9TwDXc130_provenance.
- NP822212.RAxoXLK9PwQwyPIGsizHkC6wgtOG6cXa4xQHzFvrdvydg130_assertion description "[Primary hyperoxaluria type II (PH2) is a rare monogenic disorder that is characterized by a lack of the enzyme that catalyzes the reduction of hydroxypyruvate to D-glycerate, the reduction of glyoxylate to glycolate and the oxidation of D-glycerate to hydroxypyruvate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP822212.RAxoXLK9PwQwyPIGsizHkC6wgtOG6cXa4xQHzFvrdvydg130_provenance.